About This Study
The main purpose of this study is to find out if the study drug, REGN5458, can be given safely with other multiple myeloma treatments. We also want to find out what dose of REGN5458 should be used.
Need volunteers diagnosed with multiple myeloma that has returned after being treated. The study drug REGN5458 will given along with another cancer treatment. REGN5458 will be given through an IV once a week for about 15 or 16 weeks. Then it will be given every other week or every third week. The length of your time in this study will depend on your response to the study drugs and what side affects you may have.
What Activities Are a Part of this Study?
- Informed Consent Review
- Use of Study Treatments or Placebo
- Review of Medical History
- Physical Examinations
- Study Visits and Consultations
- Laboratory and Imaging Tests
- Specimen Sample Collection
Age & Gender
- 18 - 100 years old
- All Genders
Language
- This study enrolls English and Spanish speakers
Additional Study Information
- No compensation provided
- No reimbursement offered
Study Locations
- Greater Winston-Salem, NC